1h Free Analyst Time
Respiri Ltd (RSH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.Speak directly to the analyst to clarify any post sales queries you may have.
The profile contains critical company information including:
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Respiri Ltd (Respiri), formerly iSonea Ltd, is a medical technology company that conducts research, development, and commercialization of medical devices and mobile health applications to improve the management of chronic respiratory disorders such as asthma. The company’s proprietary applications, software, and devices will help people monitor the symptoms of their conditions and increase their awareness of the risk of attack. It is an Australian e-Health SaaS provider that supports respiratory health management with a primary focus on the US healthcare industry. It offers wheezo, an asthma management tool that helps patients in the management of their health condition. Respiri is headquartered in Melbourne, Victoria, Australia.Respiri Ltd Key Recent Developments
Aug 16, 2022: Respiri : Company Secretary appointment and resignationJun 20, 2022: Leading US med-tech executive Brad Snow appointed Non-Executive Director
Apr 19, 2022: Respiri : Director Resignation
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 - About the Company- Respiri Ltd - Key Facts
- Respiri Ltd - Key Employees
- Respiri Ltd - Key Employee Biographies
- Respiri Ltd - Major Products and Services
- Respiri Ltd - History
- Respiri Ltd - Company Statement
- Respiri Ltd - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Company Overview
- Respiri Ltd - Business Description
- Geographical Segment: Australia
- Performance
- Overview
- Respiri Ltd - SWOT Analysis
- SWOT Analysis - Overview
- Respiri Ltd - Strengths
- Respiri Ltd - Weaknesses
- Respiri Ltd - Opportunities
- Respiri Ltd - Threats
- Respiri Ltd - Key Competitors
- Financial Ratios - Annual Ratios
- Performance Chart
- Financial Performance
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
- Respiri Ltd, Medical Equipment, Deals By Year, 2017 to YTD 2023
- Respiri Ltd, Medical Equipment, Deals By Type, 2017 to YTD 2023
- Respiri Ltd, Recent Deals Summary
- Aug 16, 2022: Respiri : Company Secretary appointment and resignation
- Jun 20, 2022: Leading US med-tech executive Brad Snow appointed Non-Executive Director
- Apr 19, 2022: Respiri : Director Resignation
- Methodology
- Ratio Definitions
- About the Publisher
- Contact the Publisher
- Disclaimer
- Respiri Ltd, Key Facts
- Respiri Ltd, Key Employees
- Respiri Ltd, Key Employee Biographies
- Respiri Ltd, Major Products and Services
- Respiri Ltd, History
- Respiri Ltd, Other Locations
- Respiri Ltd, Subsidiaries
- Respiri Ltd, Key Competitors
- Respiri Ltd, Annual Ratios
- Respiri Ltd, Interim Ratios
- Respiri Ltd, Medical Equipment, Deals By Year, 2017 to YTD 2023
- Respiri Ltd, Medical Equipment, Deals By Type, 2017 to YTD 2023
- Respiri Ltd, Recent Deals Summary
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
- Respiri Ltd, Performance Chart (2018 - 2022)
- Respiri Ltd, Ratio Charts
- Respiri Ltd, Medical Equipment, Deals By Year, 2017 to YTD 2023
- Respiri Ltd, Medical Equipment, Deals by Type, 2017 to YTD 2023
Companies Mentioned
A selection of companies mentioned in this report includes:
- Vision Eye Institute Ltd
- Teleflex Inc
- iNova Pharmaceuticals (Australia) Pty Ltd
- Cortical Pty Ltd
- Compumedics Ltd
- Alphapharm Pty Ltd
- Allied Healthcare Products Inc